Case Report: Iptacopan combined with intensive immunosuppressive therapy in an older adult patient with severe aplastic anemia and paroxysmal nocturnal hemoglobinuria

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare hemolytic disorder. Allogeneic hematopoietic stem cell transplantation (allo-HCT) is a standard of care as frontline treatment if a donor is available in younger patients with SAA regardless the presence of a PNH clone. However, older adult patients with SAA face high risks of infection and bleeding, poor treatment tolerance, and suboptimal overall survival after transplantation. Current guidelines recommend intensive immunosuppressive therapy (IST) as the frontline approach for older adult SAA. Here, we report a case of an older adult patient with SAA and PNH who received IST combined with iptacopan, resulting in significant improvement in both disease status and quality of life.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-11-18
DOI
https://doi.org/10.3389/fimmu.2026.1770630
Primary Topic
Complement system in diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Case Report: Iptacopan combined with intensive immunosuppressive therapy in an older adult patient with severe aplastic anemia and paroxysmal nocturnal hemoglobinuria

师锦宁, Yongchao Ma, Yuemin Gong, Guangsheng He et al.
3 links
Frontiers in Immunology
Complement system in diseases
article

Case Report: Iptacopan combined with intensive immunosuppressive therapy in an older adult patient with severe aplastic anemia and paroxysmal nocturnal hemoglobinuria

师锦宁, Yongchao Ma, Yuemin Gong, Guangsheng He, Yawen Zhang, Chengtao Qin, Ting Zhang
article en

Abstract

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare hemolytic disorder. Allogeneic hematopoietic stem cell transplantation (allo-HCT) is a standard of care as frontline treatment if a donor is available in younger patients with SAA regardless the presence of a PNH clone. However, older adult patients with SAA face high risks of infection and bleeding, poor treatment tolerance, and suboptimal overall survival after transplantation. Current guidelines recommend intensive immunosuppressive therapy (IST) as the frontline approach for older adult SAA. Here, we report a case of an older adult patient with SAA and PNH who received IST combined with iptacopan, resulting in significant improvement in both disease status and quality of life.

Frontiers in ImmunologyVol. 17
Jiangsu Province Hospital (CN), Nanjing Jiangning Hospital (CN)
Good health and well-being
Complement system in diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon